IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Syngene International IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 550.00 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Axis Bank , Credit Suisse Securities (India) , Jefferies India are the merchant bankers of Syngene International IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st July 2015.
Syngene International IPO posted revenues of ₹ 859.90 Cr. and PAT of ₹ 175.00 Cr. in FY25 on annualised basis.
Revenue:
₹ 859.90 Cr.
EBITDA Margin:
34.05
% 
Net Worth: ₹ 844.90 Cr.
Market Capitalisation:
[●]
P/E:
27.00 times
P/BV: [●]
EV/EBITDA: 0.13 times
Financial results of Syngene International IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY15 | FY14 | FY13 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 1421.50 | 1190.90 | 724.20 | ||
| Net Worth | 844.90 | 659.30 | 518.60 | ||
| Total Debt | 155.00 | 154.90 | [●] | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
859.90 | 699.50 | 550.00 | ||
EBITDA
EBITDA on annualised basis |
292.80 | 222.60 | 172.70 | ||
PAT
PAT on annualised basis |
175.00 | 134.80 | 102.10 | ||
Syngene International IPO PAT Margin is 20.35 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Syngene International IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY15 | FY14 | FY13 |
|---|---|---|---|
| EBITDA Margin (%) | 34.05 | 31.82 | 31.40 |
| PAT Margin (%) | 20.35 | 19.27 | 18.56 |
| EPS (₹) | 9.20 | 7.24 | 5.90 |
| ROE (%) | 20.71 | 20.45 | 19.69 |
| ROCE (%) | [●] | [●] | [●] |
| ROA (%) | 12.31 | 11.32 | 14.10 |
| Debt to Equity | 0.18 | 0.23 | [●] |
The market Capitalisation of Syngene International IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Syngene International IPO prospectus highlights an Return on Equity (ROE) of 20.71 % , Return on Assets (ROA) of 12.31 %, and an EBITDA Margin of 34.05 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Syngene International IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Syngene International IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Syngene International IPO has a Price-to-Earnings (PE) ratio of 27.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Syngene International IPO reported revenue of ₹ 871.60 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Syngene International IPO provide insights into sales growth, market demand, and business scalability.
Syngene International recorded an EBITDA of ₹ 292.80 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Syngene International Profit After Tax (PAT) is ₹ 175.00 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 859.90 Cr.
EBITDA Margin:
34.05
%
Net Worth: ₹ 844.90 Cr.
Market Capitalisation:
[●]
P/E:
27.00 times
P/BV: [●]
EV/EBITDA:
[●]
Syngene International operates in Pharmaceutical and Development And Manufacturing At Its Ultra Modern World Class Research And Development Facility. The Issue is listed on BSE,NSE in Aug, 2015. Syngene International IPO size was 550.00 with Issue price of 250.00 .
Merchant Banker(s) of Syngene International IPO: Axis Bank Limited , Credit Suisse Securities (India) Private Limited , Jefferies India Private Limited
Syngene International IPO subscription was 32.05 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Syngene International IPO listed at a listing price of 310.40 against the offer price of 250.00.
The current market price of Syngene International is 657.25.
Why Us?
